Shares of GSK PLC GSK inched down 0.41% to £13.35 Friday, on what proved to be an all-around positive trading session for the ...

The GSK share price has been in a strong freefall after peaking at 1,785p in September. Most recently, the GSK stock ...

The European Commission (EC) has granted approval for a single-vial, fully liquid presentation of GSK's Menveo vaccine ...

A phase 3 trial of GSK’s linerixibat in a liver disease has hit its primary endpoint, keeping the drugmaker on track to ...

GSK’s fully liquid presentation of its meningococcal vaccine Menveo has been approved by the European Commission (EC) to ...

British drugmaker GSK said on Tuesday its experimental therapy, linerixibat, met its main goal in a late-stage trial to treat ...

GSK (GSK) announced that the European Commission, EC, has approved a single-vial, fully liquid presentation of Menveo to help protect against ...

GSK said on Friday that its respiratory syncytial virus (RSV) vaccine has received approval in Japan for expanded use in ...

GSK's phase 3 GLISTEN trial demonstrated linerixibat's potential to treat relentless itch in PBC patients, meeting its ...

London: GSK plc has announced that the European Commission (EC) has approved a single-vial, fully liquid presentation of ...

Pitcairn Co. cut its holdings in GSK plc (NYSE:GSK – Free Report) by 14.1% during the 3rd quarter, according to its most ...

GSK PLC GSK shares inched down 0.63% to £13.38 Tuesday, on what proved to be an all-around poor trading session for the stock ...